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Abstract: Transforming growth factor-b (TGF-b) is a major
regulator of collagen gene expression in human skin fibroblasts.
Cellular responses to TGF-b are mediated primarily through its
cell surface type I (TbRI) and type II (TbRII) receptors.
Ultraviolet (UV) irradiation impairs TGF-b signalling largely due
to reduced TbRII gene expression, thereby decreasing type I
procollagen synthesis, in human skin fibroblasts. UV irradiation
does not alter either TbRII mRNA or protein stability, indicating
that UV reduction in TbRII expression likely results from
transcriptional or translational repression. To understand how
UV irradiation regulates TbRII transcription, we used a series of
TbRII promoter-luciferase 50-deletion constructs (covering 2 kb
of the TbRII proximal promoter) to determine transcriptional
rate in response to UV irradiation. We identified a 137-bp region
upstream of the transcriptional start site that exhibited high
promoter activity and was repressed 60% by UV irradiation,
whereas all other TbRII promoter reporter constructs exhibited
either low promoter activities or no regulation by UV
irradiation. Mutation of potential transcription factor binding
sites within the promoter region revealed that an inverted
CCAAT box (81 bp from transcription start site) is required
for promoter activity. Mutation of the CCAAT box completely
abolished UV irradiation regulation of the TbRII promoter.
Protein-binding assay, as determined by electrophoretic mobility-
shift assays (EMSAs) using the inverted CCAAT box as probe
(100/62), demonstrated significantly enhanced protein binding
in response to UV irradiation. Super shift experiments indicated
that nuclear factor Y (NFY) is able to binding to this sequence,
but NFY binding was not altered in response to UV irradiation,
indicating additional protein(s) are capable of binding this
sequence in response to UV irradiation. Taken together, these
data indicate that UV irradiation reduces TbRII expression, at
least partially, through transcriptional repression. This repression
is mediated by a 38-bp sequence in TbRII promoter, in human
skin fibroblasts.
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Introduction
The most abundant structural protein in human skin is type I
procollagen, which is responsible for the skin’s strength and resil-
iency. Dermal fibroblasts are primary cellular source for type I
collagen synthesis. Alteration of skin collagen content and organi-
zation impair wound healing, contribute to skin cancer and are
responsible for skin fragility in the elderly (1–4).
Transforming growth factor-b (TGF-b) is a major regulator of
collagen gene expression in human skin fibroblasts. Cellular
responses to TGF-b are mediated primarily through its cell surface
type I receptor (TbRI) and type II receptor (TbRII). Binding of
TGF-b to TbRII activates the intrinsic serine/threonine kinase
activity of TbRI, which phosphorylates transcription factors
Smad2 and Smad3. Phosphorylated Smad2 and Smad3 combine
with Smad4 and translocate into the nucleus, where they function
to regulate transcription of specific genes that possess TGF-b
response elements in their promoters (5–7).
Ultraviolet (UV) irradiation from the sun is a potent environ-
mental hazard capable of damaging cellular DNA and causing muta-
tions (8,9). In addition, solar UV irradiation is the primary cause of
premature skin ageing (photoageing). We have reported previously
that UV irradiation reduces type I procollagen production through
impairment of TGF-b signal transduction pathway. This reduction
is largely due to repression of TbRII gene expression (10,11). We
observed that UV irradiation significantly represses TbRII mRNA
and protein, but not TbRI, in cultured human skin fibroblasts. In
the same study, we also observed that neither TbRII mRNA stability
nor TbRII protein stability was altered after UV exposure, indicating
that UV repression of TbRII mRNA and protein must result from
reduced mRNA transcription or protein synthesis.
We report here that UV irradiation reduces TbRII expression,
at least partially, through transcriptional repression. This repres-
sion is mediated by a 38-bp sequence in TbRII promoter, in
human skin fibroblasts.
Materials and methods
Materials
Dulbecco’s modified Eagle’s medium, foetal calf serum, trypsin
solution, penicillin/streptomycin and L-glutamine were purchased
from Gibco (Invitrogen, Carlsbad, CA, USA). [c-32p]ATP was
obtained from Perkin Elmer (Boston, MA, USA). Type I procol-
lagen, TbRII and NF-Y antibodies were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). All other reagents
were purchased from Sigma-Aldrich Company (St. Louis, MO,
USA).
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Cell culture and UV irradiation
Adult human skin primary dermal fibroblasts were isolated from
punch biopsy of healthy adult normal human skin, as described
previously (10). Cells were cultured at 37°C under 5% CO2 in
Dulbecco’s modified Eagle’s medium supplemented with 10% foe-
tal bovine serum. Cells were used between passages 5 and 10. UV
irradiation of human skin primary dermal fibroblasts was per-
formed as described previously (10–12). Briefly, subconfluent cells
were irradiated with a UVB/A2 source (50 mJ/cm2) using an
Ultralite Panelite lamp containing six FS24T12 UVB-HO bulbs.
The UV irradiation intensity was monitored with an IL1400A
phototherapy radiometer and a SED240/UVB/W photodetector
(International Light, Newbury, MA, USA). A Kodacel filter was
used to remove UVC (wavelengths below 290 nm).
Promoter/reporter constructs
A series of TbRII promoter-luciferase 50-deletion constructs (cover-
ing 2 kb of TbRII proximal promoter) was kindly provided by Dr.
Seong-Jin Kim (National Institute of Health, Bethesda, MD, USA)
(13). Luciferase reporters driven by wild-type and mutant TbRII
promoter spanning from 137 to 47 were generated by PCR using
mutant templates, which were kindly provided by Dr. James W.
Freeman (Department of Medicine, University of Texas Health
Service Center, San Antonio, TX, USA) (14). PCR primers were
forward primer 50-CGCTCGAGTGAGGGGCAGCTGAAAGTC-30;
reverse primer to generate wild-type and mutants (Sp1A, Sp1C and
inverted CCAAT) reporters was 50-GCAAGCTTACGTCCAGCCCC
TAG-30; reverse primer for Sp1D mutant was 50-GCAAGCTT-AC
GTCGAATTCCTAG-30; wild-type and mutant TbRII promoter-
luciferase reporters, spanning from 100 to 62, were generated by
PCR using wild-type and mutant templates described above. PCR
primers were as follows: forward primer: 50-CGCTCGAGGGC-T
GGTCTAGGAAAC-30 and reverse primer: 50-GCCTCGAGCAGC-
TACGAGAGAGC-30. The PCR products were cloned into pGL-3
luciferase reporter using Hind III and Xho I restriction sites.
Transient transfection of TbRII promoter constructs and
luciferase assays
Human skin fibroblasts were transiently transfected and cotrans-
fected with a b-galactosidase, to provide an internal control for
transfection efficiency, and the luciferase reporters described above.
Transfection was performed by electroporation, according to the
manufacturer’s protocol (Amaxa Biosystems, Gaithersburg, MD,
USA). Aliquots containing identical b-galactosidase activity were
used for each luciferase assay. Luciferase activity was measured
using an enhanced luciferase assay kit (PharMingen International,
San Diego, CA, USA) according to the manufacturer’s protocol.
Electrophoretic mobility-shift assay and super shift assay
Electrophoretic mobility-shift assays (EMSAs) were performed as
described previously (10,15). Nuclear extracts were prepared by
nuclear and cytoplasmic extraction reagents (Pierce, Rockford, IL,
USA). Double-stranded oligonucleotide probes for EMSAs were as
follows: wild-type TbRII promoter probe spanning 100 to 62
(38 bp), 50-GGCTGGTCTAGGAAACATGATTGGCA-GCTACGAG
AGAG-30 and mutant TbRII promoter probe, 50-GGCTGGTCT-
AGGAAACATGGTGTACAGCTACGAGAGAG-30. Consensus wild-
type and mutant nuclear factor Y (NFY) probes were purchased
from Santa Cruz Biotechnology. All other oligonucleotides were
synthesized by Invitrogen. For competition experiments, a 10- to
50-fold molar excess of non-radioactive competitor probes was pre-
incubated with the nuclear extract for 30 min on ice before [32P]
probes were added. For antibody super shift assays, reactions were
performed by pre-incubating nuclear extracts (20 lg) with antibody
(2 lg) on ice for 30 min and then incubated with [32P] probes. Gels
were transferred to 3MM Whatman paper, vacuum-dried and
scanned using the STORM MolecularImager (Molecular Dynam-
ics).
RNA isolation and quantitative real-time RT-PCR
Total RNA was isolated using TRIzol reagent (Invitrogen, Carls-
bad, CA, USA) according to the manufacturer’s protocol. Total
RNA (100 ng) was reverse-transcribed using Taqman Reverse
Transcription kit (Applied Biosystems, Foster City, CA, USA).
Real-time PCR was performed on a 7900 Sequence Detector
(Applied Biosystems) using Taqman Universal PCR Master Mix
Reagents (Applied Biosystems). PCR primers and probes were
purchased from Applied Biosystems. Type I procollagen, TbRII
and 36B4 primers and probes were described previously (15). Tar-
get gene levels were normalized to the housekeeping gene 36B4, as
an internal control for quantification.
Western blot analysis
Western analysis was performed as previously described (10).
Briefly, whole-cell extracts were prepared from cells using whole-
cell extraction buffer (25 mM HEPES, 0.3 M NaCl, 1.5 mM MgCl2,
0.2 mM EDTA, 0.1% Triton X-100, 0.5 mM DTT, 20 mM b-glycer-
olphosphate, 0.1 mM Na3VO4, 2 lg/ml leupeptin and 100 lg/ml
PMSF). Protein concentrations were measured by Bio-Rad protein
assay (Bio-Rad Laboratories, Hercules, CA, USA). Proteins were
resolved on 6% or 10% SDS-PAGE, transferred to PVDF mem-
brane and reacted with primary antibodies. Protein bands were
visualized and quantified with enhanced chemifluorescence (ECF)
(Vistra ECF Western Blotting System, GE Healthcare, Piscataway,
NJ, USA) following the manufacturer’s protocol. The intensities of
each band were quantified by STORM MolecularImager (Molecu-
lar Dynamics, Sunnyvale, CA, USA) and normalized using b-actin
as loading control.
Transfection and siRNA
Human skin fibroblasts were transiently transfected with control
siRNA (50-UUCUCCGAACGUGUCACGU-30, Qiagen, Chatsworth,
CA), or NFY-A siRNA (50-CCAUCGUCUAUCAACCAGUUA-30),
and designed to target exon 6 of NFY-A (16) (Sigma-Aldrich Com-
pany, St Louis, MO, USA), as described previously (17). All siRNA
were transiently transfected into dermal fibroblasts by electropora-
tion (Amaxa Biosystems, Koeln, Germany) as described above.
Forty-eight hours after transfection, whole-cell extract and total
RNA were prepared. Protein and mRNA levels were determined by
Western blot analysis and quantitative real-time RT-PCR, respec-
tively, as described above.
Statistical analysis
Comparisons between groups were determined with the Student’s
t-test. All P-values are two-tailed and considered significant when
P < 0.05.
Results
UV irradiation represses TbRII promoter activity in human
skin fibroblasts
Ultraviolet (UV) irradiation significantly reduces type I procollagen
gene expression through impairment of TGF-b signal transduction
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Ultraviolet irradiation represses TGF-b type II receptor
pathway, largely due to repression of TbRII gene expression (11).
This impairment is not due to reduced stability of either TbRII
mRNA or protein, indicating that UV repression of expression
likely results from reduced synthesis of TbRII mRNA or protein
(data not shown). To determine whether UV irradiation alters
TbRII mRNA transcription, we transiently transfected a series of
TbRII promoter-luciferase 50-deletion constructs (covering 2 kb of
the TbRII proximal promoter) into cultured skin fibroblasts.
Twenty-four hours after transfection, cells were exposed to UV
(50 mJ/cm2). Twenty-four hours after UV irradiation, luciferase
activity was determined. These studies identified a 137 base pair
region upstream of the transcriptional start site that exhibited high
promoter activity and was significantly repressed 60% (n = 8,
P < 0.05) by UV irradiation (Fig. 1). The reporter construct
pTbRII-47/+54 also exhibited high promoter activity but was not
altered by UV irradiation. These data indicate that the TbRII pro-
moter from 137 to 46 contains transcriptional regulation ele-
ment(s) that is required for TbRII promoter activity and regulated
by UV irradiation.
TbRII promoter activity requires inverted CCAAT box in
human skin fibroblasts
Analysis of the TbRII promoter from 137 to 47 revealed three
potential SP1-binding sites and one inverted CCAAT transcription
regulation site. To determine which of these sites are required for
promoter activity and confer regulation by UV irradiation, we
generated a series of mutant TbRII promoter luciferase reporter
constructs (covering the 137 to 47 base pair region). Mutation
of each SP1 site did not alter either promoter activity or repres-
sion by UV irradiation (Fig. 2). In contrast, mutation of the
inverted CCAAT box significantly reduced both TbRII promoter
activity and responsiveness to UV irradiation (Fig. 2). These
results indicate that the inverted CCAAT box is critical element
for TbRII promoter regulation.
To further examine the activity of the inverted CCAAT site, we
generated a 38 bp TbRII promoter construct (100/62) contain-
ing the inverted CCAAT site, but excluding the SP1 sites. After
transfection and UV irradiation, we found that this 38 bp region
retained full promoter, that is, activity similar to the 137/47
construct (Fig. 2), and was repressed by UV irradiation (Fig. 3).
Mutation of the inverted CCAAT site caused loss of promoter
activity. Taken together, these data indicate that the inverted
CCAAT sequence located between 100 to 62 base pairs is
required and sufficient for TbRII proximal promoter activity and
confers responsiveness to UV irradiation.
UV irradiation increases protein binding to inverted CCAAT
box in the TbRII proximal promoter in human skin
fibroblasts
Ultraviolet (UV) irradiation repression of the TbRII promoter
may reflect altered protein binding to the inverted CCAAT region
of the promoter. To examine this possibility, we performed EMSA
using TbRII promoter 100/62 as probe (Fig. 4a). UV irradia-
tion substantially increased the amount of the retarded DNA–pro-
tein complex (Fig. 4b). This increased protein binding occurred
2 h post-UV irradiation and remained increased for at least 8 h
post-UV exposure. No DNA–protein complex was detected with
mutant CCAAT probe (Fig. 4b, right panel). To confirm the spec-
ificity of the retarded complexes formed with the wild-type probe,
we performed competition EMSA. DNA–protein complex with the
labelled 100/62 probe was completely abolished by excess unla-
belled the wild-type probe, but not by the mutant CCAAT probe
(Fig. 4c).
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Figure 1. Ultraviolet (UV) irradiation represses TbRII promoter activity in human
skin fibroblasts. Human skin fibroblasts were transiently transfected with TbRII
promoter (sequence from 137 to +54 and 47 to +54) luciferase reporter
constructs and b-galactosidase expression vector. Cells were exposed to UV
irradiation (50 mJ/cm2) 24 h after transfection, and cell lysates were prepared 24 h
post-UV irradiation. Luciferase activities were normalized to b-galactosidase activity.
Data are means  SEM for fold change in luciferase activity relative to activity in
cells transfected with control vector, pGL-3 luciferase reporter. n = 8. *P < 0.05
versus non-UV-irradiated cells.
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Figure 2. TbRII promoter activity requires inverted CCAAT box in human skin
fibroblasts. Human skin fibroblasts were transiently transfected with wild-type TbRII
promoter (sequence from 137 to 47) luciferase reporter construct, or mutant
TbRII promoter luciferase constructs in which Sp1 or inverted CCAAT box was
mutated. Cells were cotransfected with the b-galactosidase expression vector. Cells
were exposed to ultraviolet (UV) irradiation (50 mJ/cm2) 24 h after transfection,
and cell lysates were prepared 24 h post-UV irradiation. Luciferase activities were
normalized to b-galactosidase activity. Data are means  SEM for fold change in
luciferase activity relative to activity in cells transfected with wild-type TbRII
promoter luciferase construct. n = 6. *P < 0.05 versus non-UV-irradiated cells.
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Figure 3. Inverted CCAAT box confers ultraviolet (UV) irradiation repression to
TbRII promoter in human skin fibroblasts. Human skin fibroblasts were transiently
transfected with the wild-type TbRII promoter (sequence from 100 to 62)
luciferase reporter construct, or mutant TbRII promoter luciferase reporter construct
in which the inverted CCAAT box was mutated. Cells were co-transfected with the
b-galactosidase expression vector. Cells were exposed to UV irradiation (50 mJ/
cm2) 24 h after transfection, and cell lysates were prepared 24 h post-UV
irradiation. Luciferase activities were normalized to b-galactosidase activity. Data
are means  SE for fold change in luciferase activity relative to activity of wild-type
TbRII promoter luciferase reporter construct. n = 4. *P < 0.05 versus non-UV-
irradiated cells.
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NFY binds to the TbRII promoter activity but binding is
not altered by UV in human skin fibroblasts
The CCAAT box is one of the most common cis-elements present
in eukaryotic promoters and can serve as a binding site for tran-
scription factor NFY. To determine whether NFY interacts with the
inverted CCAAT box in the TbRII promoter, we performed com-
petition EMSA with labelled wild-type TbRII promoter 100/62
probe and excess unlabelled NFY consensus probe. As shown in
Fig. 5a, addition of excess NFY consensus probe reduced protein
binding to the TbRII probe. Similar reduction in binding was
observed in samples from both non-irradiated and UV-irradiated
dermal fibroblasts. In contrast, competition with excess mutant
NFY probe did not alter formation of the retarded complexes, indi-
cating that competition with NFY consensus probe was specific. To
further confirm NFY binding, we performed super shift assays with
antibody that specifically recognizes the NFY-A subunit of NFY.
Super-shifted DNA–protein–antibody complexes were detected in
samples from both UV-irradiated and non-UV-irradiated dermal
fibroblasts (Fig. 5b). These data indicate that NFY binds to the
100/62 sequence in the TbRII proximal promoter.
We next investigated whether NFY DNA binding is altered by
UV irradiation. To examine this question, we performed EMSA
and super shift EMSA with [32P] NFY consensus probe and anti-
NFY-A antibody. As shown in Fig. 5c, retarded complexes and
super-shifted bands were readily detected in nuclear extracts from
non-irradiated skin fibroblasts. Notably, the intensities of both
retarded and super-shifted bands were not altered by treatment of
fibroblasts with UV irradiation.
Taken together, these data indicate that NFY binds to the 38 bp
region of the TbRII promoter, and this binding is not regulated by
UV irradiation. Therefore, increased NFY DNA binding is not
responsible for increased DNA–protein complex formation with the
TbRII promoter, which is observed following UV irradiation.
Discussion
Transcriptional regulation of TbRII gene expression plays a key
role in modulating TGF-b responsiveness. Reduced expression of
TbRII has been identified in several types of tumor cells. Transfec-
tion of wild-type TbRII construct into such tumor cells is able to
restore their sensitivity to TGF-b and suppress cell growth (18,19).
(a)
(b) (c)
Figure 4. Ultraviolet (UV) irradiation increases protein binding to inverted CCAAT
box in the TbRII proximal promoter in human skin fibroblasts. (a) Sequence of TbRII
promoter spanning nucleotides 100 to 62 used as probes for electrophoretic
mobility-shift assays (EMSAs). Wild-type and mutant-inverted CCAAT sites are
bolded and underlined, respectively. (b) EMSAs were performed using [32P] TbRII
wild-type or mutant probes. Nuclear extracts were prepared at indicated times
after UV irradiation (50 mJ/cm2). Closed triangle indicates specific retarded
complex. Open triangle indicate non-specific bands. (c) Competition of protein
binding to TbRII wild-type probe by 50-fold molar excess unlabelled wild-type or
mutant probe. Nuclear extracts were prepared 6 h after UV irradiation. Closed
triangle indicates specific retarded complex. Results are representative of three
experiments.
(b)(a) (c)
Figure 5. Nuclear factor Y (NFY) binds to the inverted CCAAT box in the TbRII promoter in human skin fibroblasts. Fibroblasts were mock or ultraviolet (UV)-irradiated
(50 mJ/cm2), and nuclear extracts were prepared 6 h after irradiation. (a) Competition of protein binding to TbRII promoter probe (spanning from 100 to 62) by 50-fold
molar excess of unlabelled wild-type or mutant NFY probe. (b) Electrophoretic mobility-shift assays (EMSAs) with [32P] TbRII promoter probe (spanning from 100 to 62)
super shifted with control IgG or anti-NFYA antibody. Closed triangle indicates retarded complex; open triangle indicates super-shifted complex. (c) EMSA with [32P] NFY
consensus probe super shifted with control IgG or anti-NFY-A antibody. Closed triangle indicates retarded complex; open triangle indicates super-shifted complex. Results are
representative of three experiments.
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Ultraviolet irradiation represses TGF-b type II receptor
In skin dermis, TGF-b is a major mediator of fibroblast function
and extracellular matrix production. Our previous studies have
demonstrated that UV irradiation significantly reduces type I pro-
collagen gene expression, in cultured skin fibroblasts, through
impairment of TGF-b signalling, largely due to reduction of TbRII
(11). Restoration of TbRII gene expression overcomes the inhibi-
tory effect of UV on type I procollagen production. In addition,
knock-down of TbRII by siRNA reduces type I procollagen
expression, similar to UV irradiation.
In this report, we have investigated regulation of TbRII transcrip-
tion by UV irradiation in human dermal fibroblasts. We identified a
38 bp sequence (100/62), which harbours an inverted CCAAT
box, in the proximal TbRII promoter that is necessary for promoter
activity and confers inhibition by UV irradiation. Reduction in
TbRII promoter activity by UV irradiation was associated with
enhanced protein binding to the 38 bp sequence. NFY binds to the
38 bp promoter region; however, its binding was not altered in
response to UV irradiation, implying additional protein(s) are capa-
ble of binding to this sequence in response to UV irradiation.
Previous studies have identified several cis-regulatory elements
in the TbRII gene promoter (13,20). However, the role of these
cis-elements in the regulation of TbRII gene transcription appears
to be complex and cell-type dependent. We found that human
skin fibroblasts, transcription of the TbRII proximal promoter, is
dependent on a 38 bp sequence from 100 to 62. This sequence
also confers regulation by UV irradiation, which inhibits tran-
scription and induces protein binding.
CCAAT box is one the most common cis-elements present in
eukaryotic promoters. Various DNA-binding proteins interact
with this element, including NFY. NFY is a heteromeric complex
composed of three subunits: NFY-A, NFY-B and NFY-C, all
required for CCAAT binding. NFY has been shown to exert both
positive and negative gene regulation (21–24). We observed that
knock-down of NFY-A by siRNA resulted in repression of TbRII
promoter activity, indicating NFY function as a positive regulator
of TbRII gene expression, in cultured human skin fibroblasts. This
conclusion is consistent with reports from Park and others, who
studied different cell types (25,26).
Nuclear factor Y (NFY) functions via both cooperative and antag-
onistic interactions with other transcription factors (27–29). Coop-
erative interactions enhance NFY activity, which could act to repress
or stimulate promoter activity, depending on promoter context (30–
32). Conversely, antagonistic interactions act to diminish NFY func-
tion (33–35). Our data demonstrate that NFY binds to an inverted
CCAAT box, which is contained within a 38 bp sequence in the
TbRII proximal promoter. This sequence is required for promoter
activity, and repression of activity by UV irradiation is associated
with increased protein binding to this sequence. Given that NFY is
required for promoter activity, a likely scenario is that increased pro-
tein(s)-binding in response to UV irradiation antagonizes NFY func-
tion, thereby reducing transcription of the TbRII gene (Fig. 6). The
identity of the antagonistic protein(s) remains to be determined.
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